Abiosciences

Abiosciences is a biotechnology startup based in the United States, founded in 2018. The company's slogan "Discovery for Cure" reflects its dedication to leveraging single-cell genomics and bioinformatics to gain molecular insights into human diseases, with a focus on translating these insights into effective therapeutics and diagnostics. The company operates as a 10xGenomics Certified Lab, providing services to process samples to obtain scRNA datasets, and its Bioinformatics team is capable of processing multiomics data to facilitate research publication in leading journals. The last investment in Abiosciences was a Series A investment that took place on 26 May 2021. Noteworthy investors in this funding round include Green Pine Capital Partners, IDG Capital, Primavera Capital, and Sequoia Capital China. With a clear mission to alleviate human suffering from diseases such as cancer, Abiosciences aims to discover novel drug targets and therapeutic leads using advanced bioinformatics and single-cell technologies. The company firmly believes that insights from single-cell genomics research will significantly accelerate drug development and improve human health. Abiosciences extends an invitation to researchers worldwide to join in the quest to discover cures for a better future.